PNC Financial Services Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
SCM
PNC Financial Services Group's RCUS Position: Q2 2026 in Review
PNC Financial Services Group reduced its Arcus Biosciences (RCUS) stake by 4.2% in Q2 2026, selling an estimated $7.91K and leaving 7,257 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2386.
PNC Financial Services Group first reported a position in RCUS in Q2 2022 and has held it in 17 quarters since. 95 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- PNC Financial Services Group held 7,257 shares of Arcus Biosciences worth $224K as of Q2 2026.
- PNC Financial Services Group sold 320 Arcus Biosciences shares in Q2 2026, an estimated $7.91K.
- Arcus Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2386 holding.
- PNC Financial Services Group first reported a position in Arcus Biosciences in Q2 2022 and has held it in 17 quarters since.
- 95 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.